Abstract
Small interfering RNA (siRNA) can be used to selectively reduce protein expression. Tumor necrosis factor-α (TNF-α) plays a critical role in chronic inflammation. The purpose of this study is to develop, characterize and evaluate a novel TNF-α siRNA-loaded PLGA nanoparticle formulation for potential treatment of chronic inflammation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
